Latest Listings And Ipos News

The Supreme Court of Western Australia has approved Brightstar Resources’ acquisition of Aurumin Limited, setting the stage for Aurumin’s shares to be suspended and delisted from the ASX by early December.

AFT Pharmaceuticals delivered a robust first half for FY26, posting 33% revenue growth and a return to profitability, driven by strong Australian sales and recovery in Asia and international markets. The company is advancing its global footprint and R&D pipeline, positioning for sustained growth.

AFT Pharmaceuticals has reported a robust first half of FY26, posting a 33% revenue increase to a record $114.9 million and returning to profitability amid strong growth in Australia and international markets. The company’s advancing R&D pipeline and strategic licensing deals position it well for ambitious FY27 targets.

The Takeovers Panel has declared unacceptable circumstances in the Mayne Pharma acquisition, ordering Cosette Pharmaceuticals to comply with conditions preventing closure of the Salisbury manufacturing site. This ruling highlights concerns over market transparency and the integrity of the takeover process.

The Takeovers Panel has declared unacceptable circumstances in the Mayne Pharma acquisition after Cosette Pharmaceuticals changed its intentions to close the Salisbury manufacturing site, raising concerns over market transparency and regulatory approval.

Global X Management (AUS) Limited has announced estimated distribution amounts for three of its ETFs listed on the ASX AQUA Market for the period ending 30 November 2025, highlighting income opportunities for investors.

Astron Limited has received a pivotal Australian Taxation Office Class Ruling confirming capital gains tax roll-over relief for shareholders following its redomicile from Hong Kong to Australia. This development streamlines the company’s structure and offers potential long-term benefits to investors.

Tasmea Limited reported a stellar FY25 with strong revenue and profit growth, bolstered by strategic acquisitions and a robust dividend payout. The company signals continued momentum with a new acquisition announcement and targets ASX300 inclusion in 2026.

Bio-Gene Technology reports significant progress in developing its bio-insecticides Flavocide and Qcide, including new efficacy data and organic certification, positioning the company for growth amid rising global demand for safer pest control.

Alara Resources’ Oman joint venture has secured an additional $36.4 million loan facility to fund key capital projects and sustain operations at the Al Wash-hi Majaza Copper Gold Project.

Uvre Limited has secured a key Prospecting Permit for the historic Invincible Gold Project in New Zealand’s Otago Goldfields, setting the stage for exploration activities starting late 2025 and maiden drilling in 2026.

Red Mountain Mining Ltd has made a strong entrance on the US OTCQB market, surging 36% on its first day of trading as it advances key antimony and gold projects across the US and Australia.